978.1 22.1% Total Operating Expenses 4,808.5 3,848.4 960.1 24.9% Profit (Loss) 431.1 429.4 1.7 0.4% For the Company’s operation results in 2017, the total revenue and net profit increased from the year
Unit: million Baht 2 nd Quarter 2017 2 nd Quarter 2016 Group Revenues 3,276 3,278 Group Sales Volume (k tons) 188 188 Group EBITDA 64 613 P er fo rm an ce Group Net Profit (Loss) (233) 183 HRC Sales (k
government has announced various measurements ,which attributed to increasing of methyl ester and crude palm oil demand in Thailand. For natural fatty alcohols market, in 2Q/2019, it was better than 2Q/2018
subsidiaries -10.47 0.05 -10.52 -21040.00 Profit(Loss) attributable to equity holders of the company -71.46 -15.53 -55.93 -360.14 Basic Loss Per Share (Baht) -0.10 -0.04 Gross Margin -45.07% -2.21% Net Profit
selling prices dropped by 13% compared to same period last year. The Company reported a net profit of Baht 890 million during the quarter compared to a net loss of Baht 192 million for the same period last
revenue from bad debt recovery continued growing by 19% y-y and the revenue from overseas subsidiaries grew by 18% y-y. Details of each business can be described as follows: Profit and Loss Statement
relation to the gradual increasing of the policy interest rate from 0.50% in 2022 to 2.25 as of August 2023. Net Profit In 1H/2023 financial results, the consolidated profit attributable to the owners of the
wide range of economic activities, weakening purchasing powers, lowering household income, increasing number of laid off labors, high debt burden, and lowest consumers’ confidence in more than 21 years
recognized immediately in profit or loss. However, where derivatives qualified for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged. In case of Cash
trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) Consolidated Financial Statements 2017 2016 +/(-) % Revenues from sales and services . . . . % Gross profit from